SCHEMBL22717201

SCHEMBL22717201

[c]1ccc2c(c1)ncn1ccnc21

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NUDT1 P36639 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1370906 0.75 KDM4E (0.45) NUDT1
SCHEMBL29485626 0.75 KDM4E (0.45) NUDT1
SCHEMBL28182837 0.74 KDM4E (0.44) NUDT1
SCHEMBL22717083 0.71 ADORA2A (0.42) NUDT1
SCHEMBL17732805 0.67 IKBKB (0.41)
SCHEMBL5798064 0.66
SCHEMBL11922160 0.64 TNKS (0.40)
SCHEMBL24659084 0.63 NUDT1 (0.35) NUDT1
SCHEMBL15644331 0.63 NUDT1 (0.35) NUDT1
SCHEMBL2010215 0.62 NUDT1 (0.34) NUDT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3976038-A1 HETEROCYCLIC COMPOUNDS AS PRMT5 INHIBITORS Angex Pharmaceutical, Inc. (US) 2022-04-06 EP disclosed
WO-2020243178-A1 HETEROCYCLIC COMPOUNDS AS PRMT5 INHIBITORS ANGEX PHARMACEUTICAL, INC. (US) 2020-12-03 WO disclosed